Castleman Disease
- PMID: 35015419
- Bookshelf ID: NBK576394
Castleman Disease
Excerpt
Castleman disease (CD) is a rare, nonclonal lymphoproliferative disorder having distinct subtypes depending on its etiology, pathology, and clinical presentation. It can affect lymph nodes of any body region, imitating both benign and malignant malformations, including the neck, chest, abdomen, and pelvis. Pathologically it can be classified as hyaline vascular type (HV-CD), plasma cell type, mixed type, and human herpesvirus (HHV)-8 associated Castleman disease.
Clinically it manifests as the more common unicentric ( localized or unifocal ) Castleman disease (UCD) and the less common multicentric ( generalized or multifocal ) Castleman disease (MCD).
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Wu D, Lim MS, Jaffe ES. Pathology of Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):37-52. - PubMed
-
- Dispenzieri A, Gertz MA. Treatment of Castleman's disease. Curr Treat Options Oncol. 2005 May;6(3):255-66. - PubMed
-
- Han X, Zhou DB. [Advances in etiology and management of Castleman's disease]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Oct;31(5):639-43. - PubMed
-
- Shahidi H, Myers JL, Kvale PA. Castleman's disease. Mayo Clin Proc. 1995 Oct;70(10):969-77. - PubMed
-
- Simpson D. Epidemiology of Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):1-10. - PubMed
Publication types
LinkOut - more resources
Full Text Sources